Calico, the company Google launched in September to try to cure death by tackling aging and illness, now has its first official partner, the drug company AbbVie.
The companies just announced a partnership to invest up to $1.5 billion to research, develop, and bring to market drugs that could help prolong human life by fighting age-related diseases like cancer or Alzheimer's.
Calico also announced that it would be building a new research and development facility in San Francisco.
"[Our relationship with AbbVie] will greatly accelerate our efforts to understand the science of aging, advance our clinical work, and help bring important new therapies to patients everywhere," Art Levinson, CEO and founder of Calico, said in a press release.
AbbVie is a research-based biopharmaceutical company that specializes in research "in some of the most difficult-to-treat diseases," including liver disease, kidney disease, oncology, and women's health.
